Chronic obstructive pulmonary disease (COPD) is both preventable and eminently treatable, yet is still the third-leading cause of death worldwide after heart disease and stroke. In this CPD-accredited webinar, Dr Alan Peter examined the numerous combination drug trials surrounding COPD therapies and their rather interesting results. He covered such topics as inhaled steroids in COPD, LAMAs and LABAs, co-morbidity with asthma, the GOLD criteria ABCD assessment, triple therapy and a whole lot more.

Medical Academic hosted a webinar on 21 June on the topic of 'The Combination Drug Trials in COPD'. A recording is now available, accredited for 1 CPD point [Image: Rawpixel].